{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:59:48Z","timestamp":1773788388719,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["ZIA-AR-041153"],"award-info":[{"award-number":["ZIA-AR-041153"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.mayocp.2022.06.030","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T13:32:05Z","timestamp":1669987925000},"page":"100-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-6108","authenticated-orcid":false,"given":"Sara","family":"Alehashemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-9367","authenticated-orcid":false,"given":"Michael M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.mayocp.2022.06.030_bib1","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.030_bib2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/ijc.24141","article-title":"Autoimmunity and lymphomagenesis","volume":"124","author":"Goldin","year":"2009","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3899\/jrheum.181209","article-title":"Prediction of ankylosing spondylitis in the HUNT Study by a genetic risk score combining 110 single-nucleotide polymorphisms of genome-wide significance","volume":"47","author":"Rostami","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.030_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.mayocp.2022.06.030_bib5","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.22812","article-title":"A\u00a0common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland","volume":"56","author":"Thjodleifsson","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib6","first-page":"294","article-title":"HLA-B27 related arthritis and bowel inflammation, Part 2: Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis","volume":"12","author":"Mielants","year":"1985","journal-title":"J\u00a0Rheumatol"},{"issue":"9701","key":"10.1016\/j.mayocp.2022.06.030_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.030_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/MIB.0b013e318281325e","article-title":"Risk factors for lymphoma in patients with inflammatory bowel disease: a case-control study","volume":"19","author":"Afif","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.030_bib9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.mayocp.2022.06.030_bib10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/ard.2002.004721","article-title":"Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study","volume":"62","author":"Feltelius","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.030_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2004.08.028","article-title":"Medical history and risk for lymphoma: results of a population-based case-control study in Germany","volume":"41","author":"Becker","year":"2005","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.mayocp.2022.06.030_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/ard.2005.047514","article-title":"Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.mayocp.2022.06.030_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia","volume":"98","author":"Landgren","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.mayocp.2022.06.030_bib14","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/ijc.21745","article-title":"Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study","volume":"118","author":"Landgren","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.030_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/blood-2005-11-4620","article-title":"Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries","volume":"108","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2022.06.030_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.23267","article-title":"Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma","volume":"58","author":"Mellemkjaer","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.030_bib17","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.mayocp.2022.06.030_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"issue":"24","key":"10.1016\/j.mayocp.2022.06.030_bib20","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mayocp.2022.06.030_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-5-59","article-title":"Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma","volume":"5","author":"Hemminki","year":"2012","journal-title":"J\u00a0Hematol Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.06.030_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bjh.12330","article-title":"Subsequent leukaemia in autoimmune disease patients","volume":"161","author":"Hemminki","year":"2013","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.06.030_bib23","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.06.030_bib24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.38339","article-title":"Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden","volume":"66","author":"Hellgren","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.06.030_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/annonc\/mdu144","article-title":"Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.030_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/annrheumdis-2016-209270","article-title":"Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers","volume":"76","author":"Hellgren","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.030_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/03009742.2013.863969","article-title":"Increased risk of cancer for patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study","volume":"43","author":"Sun","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2017.6368","article-title":"Ankylosing spondylitis and the risk of cancer","volume":"14","author":"Chang","year":"2017","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/03009742.2020.1804612","article-title":"Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan","volume":"50","author":"Chan","year":"2021","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.06.030_bib30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00296-019-04408-3","article-title":"Malignancy risk in Korean male patients with ankylosing spondylitis","volume":"39","author":"Nam","year":"2019","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.mayocp.2022.06.030_bib31","doi-asserted-by":"crossref","first-page":"a034819","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"10.1016\/j.mayocp.2022.06.030_bib32","first-page":"2326","article-title":"Secular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017","volume":"12","author":"Yang","year":"2021","journal-title":"J\u00a0Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/BOR.0000000000000475","article-title":"Epidemiology of axial spondyloarthritis: an update","volume":"30","author":"Wang","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.030_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/pds.3952","article-title":"Validity of ankylosing spondylitis diagnoses in The Health Improvement Network","volume":"25","author":"Dubreuil","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.4711","article-title":"Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review","volume":"28","author":"Brandenburg","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.300.2.189","article-title":"Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy","volume":"300","author":"Shea","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mayocp.2022.06.030_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10552-007-0131-1","article-title":"Agreement of diagnosis and its date for hematologic malignancies and solid tumors between Medicare claims and cancer registry data","volume":"18","author":"Setoguchi","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.mayocp.2022.06.030_bib38","series-title":"SEER Cancer Statistics Review, 1975-2017","year":"2020"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.030_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/pds.5157","article-title":"Accuracy of diagnoses of inflammatory arthritis in administrative hospitalization databases","volume":"30","author":"Ward","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.mayocp.2022.06.030_bib40","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/ajg.2016.304","article-title":"Cancer in elderly onset inflammatory bowel disease: a population-based study","volume":"111","author":"Cheddani","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.030_bib41","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.030_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hon.2165","article-title":"Use of non-steroidal anti-inflammatory drugs and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis","volume":"33","author":"Ye","year":"2015","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.06.030_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ijc.33541","article-title":"Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma","volume":"149","author":"Liebow","year":"2021","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.mayocp.2022.06.030_bib44","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/ard.51.8.951","article-title":"Ankylosing spondylitis and monoclonal gammopathies","volume":"51","author":"Renier","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2022.06.030_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jbspin.2011.11.003","article-title":"Spondylarthritis and monoclonal gammopathy","volume":"79","author":"Wendling","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.030_bib46","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1088\/1361-6498\/abbe37","article-title":"Ionising radiation as a risk factor for lymphoma: a review","volume":"40","author":"Harbron","year":"2020","journal-title":"J\u00a0Radiol Prot"},{"issue":"11","key":"10.1016\/j.mayocp.2022.06.030_bib47","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/acr.22055","article-title":"Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US Medicare program","volume":"65","author":"Zhang","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"}],"updated-by":[{"DOI":"10.1016\/j.mayocp.2023.01.022","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000}}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T13:04:54Z","timestamp":1681304694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622003913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0025619622003913"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.06.030","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.mayocp.2023.01.022","asserted-by":"object"}]},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}